Biosimilars 101: a q&a with sonia t. oskouei, cardinal health vice president of biosimilars

Dublin, ohio, nov. 4, 2021 /prnewswire/ -- biologics are the fastest growing class of drugs in the u.s.; they bring innovative, life-changing treatments to patients with cancer and chronic diseases. due to exclusive patents, they are also very expensive and out of reach for many.

CAH Ratings Summary

CAH Quant Ranking